Rhythm Pharmaceuticals, Inc. (RYTM)
87.92
+1.21
(+1.40%)
USD |
NASDAQ |
Oct 15, 16:00
87.92
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Price : 87.92 for Oct. 15, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | 86.41 | 88.14 | 85.38 | 86.71 | 585836.0 |
| Oct 13, 2026 | 89.63 | 90.50 | 86.35 | 86.61 | 623191.0 |
| Oct 12, 2026 | 91.05 | 91.42 | 89.49 | 89.82 | 543818.0 |
| Oct 09, 2026 | 89.67 | 93.35 | 89.41 | 90.78 | 1.411M |
| Oct 08, 2026 | 89.05 | 90.94 | 87.01 | 89.64 | 1.009M |
| Oct 07, 2026 | 90.77 | 91.37 | 88.23 | 88.45 | 939420.0 |
| Oct 06, 2026 | 92.55 | 94.47 | 90.07 | 90.77 | 992872.0 |
| Oct 05, 2026 | 93.95 | 94.41 | 89.53 | 92.45 | 1.027M |
| Oct 02, 2026 | 94.97 | 95.32 | 92.66 | 92.83 | 503543.0 |
| Oct 01, 2026 | 95.34 | 96.48 | 93.00 | 93.41 | 850608.0 |
| Sep 30, 2026 | 96.67 | 97.37 | 95.10 | 95.22 | 737178.0 |
| Sep 29, 2026 | 97.92 | 98.91 | 94.51 | 95.71 | 810857.0 |
| Sep 28, 2026 | 98.01 | 99.15 | 95.27 | 98.56 | 897361.0 |
| Sep 25, 2026 | 98.41 | 99.44 | 96.35 | 98.66 | 864255.0 |
| Sep 24, 2026 | 97.73 | 99.28 | 95.38 | 98.31 | 730812.0 |
| Sep 23, 2026 | 99.27 | 100.02 | 96.47 | 98.24 | 696414.0 |
| Sep 22, 2026 | 100.44 | 101.85 | 98.69 | 99.27 | 499891.0 |
| Sep 21, 2026 | 98.47 | 100.76 | 97.54 | 98.83 | 613603.0 |
| Sep 18, 2026 | 99.36 | 99.36 | 96.88 | 97.71 | 1.125M |
| Sep 17, 2026 | 101.17 | 102.00 | 98.80 | 99.02 | 617733.0 |
| Sep 16, 2026 | 97.69 | 100.85 | 97.06 | 98.01 | 921422.0 |
| Sep 15, 2026 | 101.66 | 101.66 | 96.14 | 96.77 | 914276.0 |
| Sep 14, 2026 | 105.27 | 105.93 | 101.09 | 102.44 | 789707.0 |
| Sep 11, 2026 | 102.96 | 106.57 | 102.24 | 104.71 | 573722.0 |
| Sep 10, 2026 | 99.88 | 102.89 | 99.88 | 102.20 | 422888.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.98 |
| BioMarin Pharmaceutical, Inc. | 56.03 |
| Cytokinetics, Inc. | 63.94 |
| Exelixis, Inc. | 62.84 |
| Ionis Pharmaceuticals, Inc. | 44.14 |
Price Related Metrics
| PS Ratio | 24.71 |
| PEG Ratio | -8.519 |
| Price to Book Value | 58.75 |
| Earnings Yield | -3.55% |
| Market Cap | 6.050B |
| PEGY Ratio | -8.519 |